5 employees
DeepKinase is a biotechnology company that commercializes PCT patented technology proteomics platform DoTK (Deep Omics of Tyrosine Kinase).
2019
DeepKinase 旦白志 raised undisclosed on January 1, 2022
Investors: 博远资本 and FreeS Fund 峰瑞资本